Ryeo gang Son

Dr. Ryeo gang Son

Department of Biotechnology and Bioinformatics, Korea University, Sejong, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2023 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
KPKi Sung Park
Ki Sung Park
ACAnna Choi
Anna Choi
HKHyun Jung Kim
Hyun Jung Kim
Insu ParkInsu Park
Insu Park
MEMi-Suk Eom
Mi-Suk Eom
SPSeung Pil Pack
Seung Pil Pack

3 January 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MOHAMED A.A. ABDELHAMIDMOHAMED A.A. ABDELHAMID
MOHAMED A.A. ABDELHAMID
MKMiran Ki
Miran Ki
AAAmer Ali
Amer Ali
RSRyeo gang Son
Ryeo gang Son
SPSeung Pil Pack
Seung Pil Pack
Recently, the potential use of nanoparticles for the targeted delivery of therapeutic and diagnostic agents has garnered increased interest. Several nanoparticle drug delivery systems have been developed for cancer treatment. Typically, protein-based nanocarriers offer several advantages, including biodegradability and biocompatibility. Using genetic engineering or chemical conjugation approaches, well-known naturally occurring protein nanoparticles can be further prepared, engineered, and functionalized in their self-assembly to meet the demands of clinical production efficiency. Accordingly, promising protein nanoparticles have been developed with outstanding tumor-targeting capabilities, ultimately overcoming multidrug resistance issues, in vivo delivery barriers, and mimicking the tumor microenvironment. Bioinspired by natural nanoparticles, advanced computational techniques have been harnessed for the programmable design of highly homogenous protein nanoparticles, which could open new routes for the rational design of vaccines and drug formulations. The current review aims to present several significant advancements made in protein nanoparticle technology, and their use in cancer therapy. Additionally, tailored construction methods and therapeutic applications of engineered protein-based nanoparticles are discussed.

20 July 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
MOHAMED A.A. ABDELHAMIDMOHAMED A.A. ABDELHAMID
MOHAMED A.A. ABDELHAMID
RSRyeo gang Son
Ryeo gang Son
MKMiran Ki
Miran Ki
SPSeung Pil Pack
Seung Pil Pack

1 January 2021 in Immune Network
Verified
Journal Article
Open access
PDF file
JHJi Hwa Hong
Ji Hwa Hong
SKSang Hoon Kim
Sang Hoon Kim
HKHyun Gyung Kim
Hyun Gyung Kim
JJJun Ho Jang
Jun Ho Jang
RSRyeo gang Son
Ryeo gang Son
YJYong Woo Jung
Yong Woo Jung
Hong JH, et al. Immune Netw. 2021 Jun;21(3):e24. https://doi.org/10.4110/in.2021.21.e24